BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 4398120)

  • 1. In vivo release of newly synthesized catecholamines from the hypothalamus by amphetamine.
    Philippu A; Glowinski J; Besson MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(1):1-8. PubMed ID: 4275627
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals.
    Warenycia MW; McKenzie GM
    J Neural Transm; 1987; 70(3-4):217-32. PubMed ID: 3119772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.
    Cools AR; Van Rossum JM
    Psychopharmacologia; 1976 Feb; 45(3):243-54. PubMed ID: 175391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
    Chiueh CC; Moore KE
    J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathway.
    Besson MJ; Cheramy A; Gauchy C; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):101-5. PubMed ID: 4267960
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus.
    McKenzie GM; Szerb JC
    J Pharmacol Exp Ther; 1968 Aug; 162(2):302-8. PubMed ID: 4385909
    [No Abstract]   [Full Text] [Related]  

  • 7. Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamine.
    Chiueh CC; Moore KE
    Brain Res; 1973 Feb; 50(1):221-5. PubMed ID: 4690549
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo spontaneous and evoked release of newly synthesized dopamine in the cat caudate nucleus.
    Besson MJ; Cheramy A; Gauchy C; Glowinski J
    Adv Neurol; 1974; 5():69-78. PubMed ID: 4155237
    [No Abstract]   [Full Text] [Related]  

  • 9. The release in vivo of dopamine synthesized from labelled precursors in the caudate nucleus of the cat.
    Riddell D; Szerb JC
    J Neurochem; 1971 Jun; 18(6):989-1006. PubMed ID: 4398120
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.